You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

OLMESARTAN MEDOXOMIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Olmesartan Medoxomil, and what generic alternatives are available?

Olmesartan Medoxomil is a drug marketed by Accord Hlthcare, Alembic, Alkem Labs Ltd, Amneal, Aurobindo Pharma, Chartwell Rx, Glenmark Pharms Ltd, Inventia, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Prinston Inc, Qilu, Rising, Sandoz, Sciegen Pharms Inc, Sunshine, Teva Pharms Usa, Torrent, Umedica, Zydus Pharms, Natco Pharma Usa, and Endo Operations. and is included in thirty-six NDAs.

The generic ingredient in OLMESARTAN MEDOXOMIL is amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. There are fifty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OLMESARTAN MEDOXOMIL?
  • What are the global sales for OLMESARTAN MEDOXOMIL?
  • What is Average Wholesale Price for OLMESARTAN MEDOXOMIL?
Drug patent expirations by year for OLMESARTAN MEDOXOMIL
Drug Prices for OLMESARTAN MEDOXOMIL

See drug prices for OLMESARTAN MEDOXOMIL

Recent Clinical Trials for OLMESARTAN MEDOXOMIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMSPhase 3
Seoul National University Bundang HospitalPhase 4
Shenzhen People's HospitalPhase 2

See all OLMESARTAN MEDOXOMIL clinical trials

Pharmacology for OLMESARTAN MEDOXOMIL
Medical Subject Heading (MeSH) Categories for OLMESARTAN MEDOXOMIL
Paragraph IV (Patent) Challenges for OLMESARTAN MEDOXOMIL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
BENICAR Tablets olmesartan medoxomil 5 mg, 20 mg and 40 mg 021286 1 2006-04-25

US Patents and Regulatory Information for OLMESARTAN MEDOXOMIL

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.